Evaluation of the MD Anderson tumor score for diffuse large B‐cell lymphoma in the rituximab era-Reference-Cited by-同舟云学术

Evaluation of the MD Anderson tumor score for diffuse large B‐cell lymphoma in the rituximab era

Published:2020-02-18 Issue:5 Volume:104 Page:400-408
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Gutierrez Antonio¹^ORCID,Bento Leyre¹,Diaz‐Lopez Antonio²,Barranco Gilberto²,Garcia‐Recio Marta¹,Lopez‐Guillermo Armando³,Dlouhy Ivan³^ORCID,Rovira Jordina³,Rodriguez Mario⁴,Sanchez Pina Jose María⁴,Baile Monica⁵,Martín Alejandro⁵,Novelli Silvana⁶^ORCID,Sancho Juan‐Manuel⁷^ORCID,García Olga⁷,Salar Antonio⁸^ORCID,Bastos‐Oreiro Mariana⁹,Rodriguez‐Salazar Mª José¹⁰,Fernandez Ruben¹¹,Cruz Fatima¹²,Queizan Jose Antonio¹³,González de Villambrosia Sonia¹⁴,Cordoba Raul¹⁵,López Andres¹⁶,Luzardo Hugo¹⁷,García Daniel¹⁸,Sastre‐Serra Jordi¹⁹,Garcia Juan Fernando²²⁰,Montalban Carlos²,Cabanillas Fernando²¹,Rodríguez Jose²

Affiliation:

1. Lymphoma Unit Department of Hematology Hospital Universitari Son Espases/IdISBa Palma Spain

2. Department of Translational Research MD Anderson Cancer Center Madrid Spain

3. Hospital Clinic de Barcelona Barcelona Spain

4. Hospital Universitario 12 de Octubre Madrid Spain

5. Hospital Clinico Universitario de Salamanca (CAUSA/IBSAL) Salamanca Spain

6. Department of Hematology Hospital de la Santa Creu I Sant Pau Barcelona Spain

7. Hospital Universitari Germans Trias i Pujol Barcelona Spain

8. Department of Hematology Hospital del Mar Barcelona Spain

9. Department of Hematology Gregorio Marañón General University Hospital (HGUGM) Madrid Spain

10. Hospital Universitario de Canarias Santa Cruz de Tenerife Spain

11. Department of Hematology Hospital de Cabueñes Gijon Spain